Discover the full record of transactions filed by Ling Karen, Director. Officer active across 2 companies, notably TherapeuticsMD, Inc.. Cumulatively, 7 disclosures have been published. Total volume traded: €43k. The latest transaction was filed on 26 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Ling Karen serves as a Director at TherapeuticsMD, Inc. and iRhythm Technologies, Inc. She participates in the governance of these companies and strategic decision-making. Her expertise is valuable in guiding direction and ensuring performance.